2021 Form 10-K Financial Statement
#000149315222007560 Filed on March 23, 2022
Income Statement
| Concept | 2021 | 2020 |
|---|---|---|
| Revenue | $0.00 | $0.00 |
| YoY Change | ||
| Cost Of Revenue | ||
| YoY Change | ||
| Gross Profit | ||
| YoY Change | ||
| Gross Profit Margin | ||
| Selling, General & Admin | $2.598M | $1.870M |
| YoY Change | 38.93% | 21.43% |
| % of Gross Profit | ||
| Research & Development | $25.76M | $7.684M |
| YoY Change | 235.24% | 22.56% |
| % of Gross Profit | ||
| Depreciation & Amortization | $303.2K | $385.6K |
| YoY Change | -21.36% | 13.74% |
| % of Gross Profit | ||
| Operating Expenses | $28.36M | $9.556M |
| YoY Change | 196.73% | 22.43% |
| Operating Profit | -$28.36M | -$9.556M |
| YoY Change | 196.73% | 22.43% |
| Interest Expense | -$1.249M | $120.00 |
| YoY Change | -1041008.33% | -24.53% |
| % of Operating Profit | ||
| Other Income/Expense, Net | -$1.249M | $81.99K |
| YoY Change | -1623.8% | -81.61% |
| Pretax Income | -$29.61M | -$9.474M |
| YoY Change | 212.48% | 28.74% |
| Income Tax | ||
| % Of Pretax Income | ||
| Net Earnings | -$29.61M | -$9.474M |
| YoY Change | 212.48% | 28.74% |
| Net Earnings / Revenue | ||
| Basic Earnings Per Share | -$2.21 | |
| Diluted Earnings Per Share | -$2.212M | -$922.1K |
| COMMON SHARES | ||
| Basic Shares Outstanding | 13.38M shares | |
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2021 | 2020 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $84.29M | $11.64M |
| YoY Change | 624.11% | -37.89% |
| Cash & Equivalents | $84.29M | $11.64M |
| Short-Term Investments | ||
| Other Short-Term Assets | $766.8K | $340.0K |
| YoY Change | 125.54% | 6.25% |
| Inventory | ||
| Prepaid Expenses | ||
| Receivables | ||
| Other Receivables | ||
| Total Short-Term Assets | $85.35M | $12.17M |
| YoY Change | 601.33% | -36.78% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $554.4K | $790.0K |
| YoY Change | -29.83% | -23.3% |
| Goodwill | ||
| YoY Change | ||
| Intangibles | ||
| YoY Change | ||
| Long-Term Investments | ||
| YoY Change | ||
| Other Assets | ||
| YoY Change | ||
| Total Long-Term Assets | $554.3K | $790.0K |
| YoY Change | -29.83% | -23.3% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $85.35M | $12.17M |
| Total Long-Term Assets | $554.3K | $790.0K |
| Total Assets | $85.91M | $12.96M |
| YoY Change | 562.86% | -36.09% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $1.507M | $220.0K |
| YoY Change | 585.05% | 57.14% |
| Accrued Expenses | $854.0K | $960.0K |
| YoY Change | -11.05% | 26.32% |
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Long-Term Debt Due | $5.850K | $10.00K |
| YoY Change | -41.5% | 0.0% |
| Total Short-Term Liabilities | $2.506M | $1.190M |
| YoY Change | 110.56% | 30.77% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $14.63M | $10.00K |
| YoY Change | 146183.7% | 0.0% |
| Other Long-Term Liabilities | $61.77K | $60.00K |
| YoY Change | 2.95% | 0.0% |
| Total Long-Term Liabilities | $14.69M | $70.00K |
| YoY Change | 20885.91% | 0.0% |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $2.506M | $1.190M |
| Total Long-Term Liabilities | $14.69M | $70.00K |
| Total Liabilities | $17.20M | $1.250M |
| YoY Change | 1275.67% | 27.55% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | ||
| YoY Change | ||
| Common Stock | ||
| YoY Change | ||
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | $68.71M | $11.70M |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $85.91M | $12.96M |
| YoY Change | 562.86% | -36.09% |
Cashflow Statement
| Concept | 2021 | 2020 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | -$29.61M | -$9.474M |
| YoY Change | 212.48% | 28.74% |
| Depreciation, Depletion And Amortization | $303.2K | $385.6K |
| YoY Change | -21.36% | 13.74% |
| Cash From Operating Activities | -$20.31M | -$7.146M |
| YoY Change | 184.25% | 19.12% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | -$81.90K | -$89.37K |
| YoY Change | -8.36% | -76.49% |
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | $500.00 | $0.00 |
| YoY Change | -100.0% | |
| Cash From Investing Activities | -$81.40K | -$89.37K |
| YoY Change | -8.92% | -101.05% |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | ||
| YoY Change | ||
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | 93.04M | $138.0K |
| YoY Change | 67336.75% | -46.79% |
| NET CHANGE | ||
| Cash From Operating Activities | -20.31M | -$7.146M |
| Cash From Investing Activities | -81.40K | -$89.37K |
| Cash From Financing Activities | 93.04M | $138.0K |
| Net Change In Cash | 72.65M | -$7.097M |
| YoY Change | -1123.64% | -354.34% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | -$20.31M | -$7.146M |
| Capital Expenditures | -$81.90K | -$89.37K |
| Free Cash Flow | -$20.23M | -$7.056M |
| YoY Change | 186.69% | 25.59% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2020Q4 | us-gaap |
Deferred Costs Current
DeferredCostsCurrent
|
USD | |
| CY2020Q4 | us-gaap |
Long Term Notes Payable
LongTermNotesPayable
|
USD | |
| CY2021Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
USD | |
| CY2020Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
USD | |
| CY2020 | CELC |
Loss On Sale Of Fixed Assets
LossOnSaleOfFixedAssets
|
USD | |
| CY2020 | CELC |
Issuance Of Common Stock Licensing Agreement
IssuanceOfCommonStockLicensingAgreement
|
USD | |
| CY2020 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
USD | |
| CY2020 | CELC |
Payment In Kind Interest
PaymentInKindInterest
|
USD | |
| CY2020 | CELC |
Loss On Disposition Of Assets
LossOnDispositionOfAssets
|
USD | |
| CY2020 | CELC |
Increase Decrease In Payroll Tax Receivables
IncreaseDecreaseInPayrollTaxReceivables
|
USD | |
| CY2020 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
USD | |
| CY2020 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
USD | |
| CY2020 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
USD | |
| CY2020 | CELC |
Proceeds From Follow On Offering Net Of Underwriting Discounts And Offering Costs
ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts
|
USD | |
| CY2020 | us-gaap |
Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
|
USD | |
| CY2020 | CELC |
Registration Statement Costs Included In Accounts Payable
RegistrationStatementCostsIncludedInAccountsPayable
|
USD | |
| CY2021 | CELC |
Property And Equipment Included In Accounts Payable
PropertyAndEquipmentIncludedInAccountsPayable
|
USD | |
| CY2020 | us-gaap |
Stock Issued1
StockIssued1
|
USD | |
| CY2020Q4 | us-gaap |
Deferred Costs Current
DeferredCostsCurrent
|
USD | |
| CY2020Q4 | CELC |
Accrued Clinical Trial Expense
AccruedClinicalTrialExpense
|
USD | |
| CY2021Q4 | CELC |
Lessee Operating Lease Liability Amount Representing Services
LesseeOperatingLeaseLiabilityAmountRepresentingServices
|
USD | |
| CY2021 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
USD | |
| CY2020 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
USD | |
| CY2021Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
USD | |
| CY2020Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
USD |
